VIVOSIM LABS, INC. (VIVS) Capital expenditures 2017–2026
VIVOSIM LABS, INC. (VIVS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2026 · since FY2017: $1.4M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $0 | -100.0% |
| FY2025 | $13,000 | -69.0% |
| FY2024 | $42,000 | -89.4% |
| FY2023 | $396,000 | -3.2% |
| FY2022 | $409,000 | +1.0% |
| FY2021 | $405,000 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $79,000 | -65.0% |
| FY2018 | $226,000 | -83.3% |
| FY2017 | $1.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice